Home
About Us
Leadership
News
Technology
- Overview
- Publications
Pipeline
Contact Us

Andrew Summerfield

N8 Medical > Articles by: Andrew Summerfield

N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant

July 5, 2022 7:17 pmJuly 5, 2022

N8 Medical News

Here you will find the latest information, including: press releases, events and presentations and blog posts.

Newsletter Sign-up

Interested in hearing whats new with N8 Medical? Sign-up to join our newsletter.

Email address:

Leave this field empty if you're human:

Recent Posts

N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant
N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes
Health Canada Grants Emergency Use Authorization for N8 Medical CeraShield™ Endotracheal Tubes in Mechanically Ventilated COVID-19 Patients
Frost & Sullivan awards N8 Medical New Product Innovation Award for its Platform Medical Device Technology to Prevent Hospital-Acquired Infections
N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical, LLC

N8 Medical, LLC (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins. These proprietary ceragenin compounds impart unique properties to medical devices. Ceragenin-based medical devices are designed to address the multibillion dollar public health and economic burden associated with device-related infections and other complications associated with medical devices.

About Us
Leadership
News
Technology
Pipeline
Contact Us

© 2019-2021 N8 Medical, LLC. All Rights Reserved. Privacy Policy

Menu

Home
About Us
Leadership
News
Technology
- Overview
- Publications
Pipeline
Contact Us